AGL
Agilon Health, Inc. NYSE Listed Apr 15, 2021$60.65
Mkt Cap $1.0B
52w Low $7.48
68.6% of range
52w High $85.00
50d MA $18.52
200d MA $22.22
P/E (TTM)
-1.2x
EV/EBITDA
-0.4x
P/B
3.9x
Debt/Equity
0.3x
ROE
-83.1%
P/FCF
-2.4x
RSI (14)
—
ATR (14)
—
Beta
0.33
50d MA
$18.52
200d MA
$22.22
Avg Volume
322.4K
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
6210 East US Highway 290 · Austin, TX 78723 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 1.04 | 1.80 | +73.1% | 27.85 | +56.5% | +117.8% | — | — | — | — | — |
| Feb 25, 2026 | AMC | -6.75 | -11.50 | -70.4% | 12.50 | -1.0% | +19.0% | +17.8% | +23.1% | +13.5% | +39.7% | — |
| Nov 4, 2025 | AMC | -0.18 | -0.27 | -50.0% | 18.11 | +3.0% | +4.0% | -3.8% | -7.9% | -8.9% | -14.6% | — |
| Aug 4, 2025 | AMC | -0.11 | -0.25 | -127.3% | 45.50 | -43.4% | -51.6% | -51.1% | -51.9% | -52.0% | -52.6% | — |
| May 6, 2025 | AMC | -0.01 | 0.03 | +393.0% | 111.50 | +5.6% | -24.0% | -27.8% | -35.2% | -33.4% | -39.5% | — |
| Feb 25, 2025 | AMC | -0.18 | -0.25 | -38.9% | 90.75 | -10.7% | -7.4% | -7.7% | -14.0% | -17.9% | -12.7% | — |
| Nov 7, 2024 | AMC | -0.10 | -0.29 | -190.0% | 69.75 | -33.3% | -34.1% | -22.6% | -33.0% | -32.6% | -38.7% | — |
| Aug 6, 2024 | AMC | -0.07 | -0.07 | +0.0% | 155.50 | +0.0% | -9.3% | -10.0% | -11.3% | -14.3% | -10.3% | — |
| May 7, 2024 | AMC | -0.02 | 0.01 | +150.0% | 124.50 | +6.4% | +4.2% | +5.6% | +4.2% | +4.6% | +10.4% | — |
| Feb 27, 2024 | AMC | -0.28 | -0.41 | -46.4% | 162.00 | -5.6% | -1.9% | -5.4% | -6.8% | -6.6% | -7.7% | — |
| Nov 2, 2023 | AMC | -0.05 | -0.06 | -20.0% | 422.25 | -14.4% | -13.2% | -22.4% | -19.1% | -24.7% | -30.9% | — |
| Aug 3, 2023 | AMC | -0.01 | -0.04 | -300.0% | 476.50 | +2.8% | +2.2% | +5.7% | +5.1% | +1.5% | +0.3% | — |
| May 9, 2023 | AMC | 0.03 | 0.04 | +33.3% | 650.25 | +2.8% | -3.9% | -3.2% | -7.2% | -8.5% | -11.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7 | Jefferies | Upgrade | Hold → Buy | $48 | $27.85 | $43.59 | +56.5% | +117.8% | +94.7% | — | — | — |
| May 7 | Deutsche Bank | Upgrade | Hold → Buy | $49 | $27.85 | $43.59 | +56.5% | +117.8% | +94.7% | — | — | — |
| May 4 | JP Morgan | Downgrade | Neutral → Underweight | $21 | $29.58 | $27.58 | -6.8% | -8.9% | -9.6% | -5.8% | +105.1% | +83.3% |
| Apr 2 | Benchmark | Maintains | Buy → Buy | — | $9.75 | $9.32 | -4.4% | +10.2% | +43.2% | +70.2% | +89.4% | +103.5% |
| Mar 3 | Citigroup | Maintains | Neutral → Neutral | — | $15.39 | $15.22 | -1.1% | -7.8% | +13.5% | +7.9% | -2.8% | -2.5% |
| Feb 27 | Barclays | Maintains | Underweight → Underweight | — | $14.87 | $15.00 | +0.9% | -0.9% | +3.5% | -4.6% | +17.4% | +11.7% |
| Feb 27 | Wells Fargo | Maintains | Overweight → Overweight | — | $14.87 | $15.00 | +0.9% | -0.9% | +3.5% | -4.6% | +17.4% | +11.7% |
| Nov 6 | Barclays | Maintains | Underweight → Underweight | — | $18.84 | $18.43 | -2.2% | -7.5% | -11.5% | -12.5% | -17.9% | -16.7% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $18.11 | $18.66 | +3.0% | +4.0% | -3.8% | -7.9% | -8.9% | -14.6% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $28.00 | $28.00 | +0.0% | -5.4% | -2.7% | -8.9% | -15.5% | -20.4% |
| Aug 20 | Bernstein | Downgrade | Outperform → Market Perform | — | $31.25 | $29.75 | -4.8% | -3.2% | -1.6% | +6.4% | +10.4% | -1.6% |
| Aug 15 | Jefferies | Maintains | Hold → Hold | — | $26.50 | $26.50 | +0.0% | +4.7% | +16.0% | +17.9% | +14.2% | +16.0% |
| Aug 14 | Baird | Maintains | Neutral → Neutral | — | $26.25 | $25.00 | -4.8% | +1.0% | +5.7% | +17.1% | +19.0% | +15.2% |
| Aug 6 | Barclays | Maintains | Underweight → Underweight | — | $22.00 | $21.45 | -2.5% | +1.1% | -0.5% | -0.7% | -1.9% | +1.3% |
| Aug 6 | Benchmark | Maintains | Buy → Buy | — | $22.00 | $21.45 | -2.5% | +1.1% | -0.5% | -0.7% | -1.9% | +1.3% |
| Aug 6 | Citigroup | Downgrade | Buy → Neutral | — | $22.00 | $21.45 | -2.5% | +1.1% | -0.5% | -0.7% | -1.9% | +1.3% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $59.75 | $61.00 | +2.1% | -4.2% | -3.3% | -6.7% | -5.9% | -7.9% |
| May 29 | Bernstein | Maintains | Outperform → Outperform | — | $58.75 | $58.75 | +0.0% | -5.1% | -5.5% | -4.3% | -3.4% | -6.8% |
| May 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $74.25 | $74.00 | -0.3% | -9.1% | -10.1% | -14.1% | -17.5% | -21.2% |
| May 8 | Barclays | Maintains | Underweight → Underweight | — | $84.75 | $84.00 | -0.9% | -5.0% | -14.7% | -12.4% | -20.4% | -21.2% |
| May 8 | Goldman Sachs | Maintains | Neutral → Neutral | — | $84.75 | $84.00 | -0.9% | -5.0% | -14.7% | -12.4% | -20.4% | -21.2% |
| Apr 28 | JMP Securities | Maintains | Market Perform → Market Perform | — | $97.50 | $97.75 | +0.3% | -1.5% | -2.6% | +9.2% | +0.8% | +6.7% |
| Apr 25 | Citigroup | Upgrade | Neutral → Buy | — | $95.50 | $99.75 | +4.5% | +2.1% | +0.5% | -0.5% | +11.5% | +2.9% |
| Apr 15 | Baird | Maintains | Neutral → Neutral | — | $140.00 | $137.50 | -1.8% | -1.2% | -2.3% | -28.6% | -26.1% | -27.9% |
| Apr 15 | TD Cowen | Maintains | Hold → Hold | — | $140.00 | $137.50 | -1.8% | -1.2% | -2.3% | -28.6% | -26.1% | -27.9% |
| Apr 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $106.25 | $135.25 | +27.3% | +26.1% | +21.9% | +29.4% | +33.6% | +31.8% |
| Apr 8 | Bernstein | Upgrade | Market Perform → Outperform | — | $106.25 | $135.25 | +27.3% | +26.1% | +21.9% | +29.4% | +33.6% | +31.8% |
| Mar 21 | Needham | Maintains | Hold → Hold | — | $102.50 | $103.00 | +0.5% | +10.5% | +9.3% | +9.3% | +10.2% | +12.4% |
| Feb 26 | Citizens Capital Markets | Maintains | Market Perform → Market Perform | — | $90.75 | $81.00 | -10.7% | -7.4% | -7.7% | -14.0% | -17.9% | -12.7% |
| Feb 26 | Needham | Maintains | Hold → Hold | — | $90.75 | $81.00 | -10.7% | -7.4% | -7.7% | -14.0% | -17.9% | -12.7% |
| Feb 26 | Stifel | Maintains | Hold → Hold | — | $90.75 | $81.00 | -10.7% | -7.4% | -7.7% | -14.0% | -17.9% | -12.7% |
| Feb 26 | RBC Capital | Maintains | Outperform → Outperform | — | $90.75 | $81.00 | -10.7% | -7.4% | -7.7% | -14.0% | -17.9% | -12.7% |
| Jan 15 | Bernstein | Maintains | Market Perform → Market Perform | — | $68.75 | $72.00 | +4.7% | +2.5% | +7.6% | +12.4% | +24.0% | +29.1% |
| Jan 10 | Citigroup | Upgrade | Sell → Neutral | — | $54.75 | $55.00 | +0.5% | +11.0% | +31.5% | +25.6% | +28.8% | +35.2% |
| Jan 10 | Needham | Maintains | Hold → Hold | — | $54.75 | $55.00 | +0.5% | +11.0% | +31.5% | +25.6% | +28.8% | +35.2% |
| Nov 19 | RBC Capital | Maintains | Outperform → Outperform | — | $39.25 | $39.00 | -0.6% | +1.3% | +6.4% | +13.4% | +20.4% | +43.9% |
| Nov 13 | Citigroup | Maintains | Sell → Sell | — | $46.75 | $46.75 | +0.0% | +0.5% | -8.6% | -15.5% | -16.0% | -15.0% |
| Nov 12 | Stifel | Maintains | Hold → Hold | — | $54.00 | $53.25 | -1.4% | -13.4% | -13.0% | -20.8% | -26.9% | -27.3% |
| Nov 11 | JMP Securities | Downgrade | Market Outperform → Market Perform | — | $46.00 | $46.50 | +1.1% | +17.4% | +1.6% | +2.2% | -7.1% | -14.1% |
| Nov 11 | Barclays | Maintains | Underweight → Underweight | — | $46.00 | $46.50 | +1.1% | +17.4% | +1.6% | +2.2% | -7.1% | -14.1% |
| Nov 11 | TD Cowen | Maintains | Hold → Hold | — | $46.00 | $46.50 | +1.1% | +17.4% | +1.6% | +2.2% | -7.1% | -14.1% |
| Nov 8 | William Blair | Downgrade | Outperform → Market Perform | — | $69.75 | $46.50 | -33.3% | -34.1% | -22.6% | -33.0% | -32.6% | -38.7% |
| Oct 29 | Citigroup | Downgrade | Neutral → Sell | — | $67.50 | $66.00 | -2.2% | -6.7% | -8.9% | -5.6% | +0.0% | -1.1% |
| Oct 8 | Evercore ISI | Maintains | In Line → In Line | — | $78.75 | $78.00 | -1.0% | +0.0% | -1.0% | +5.4% | +2.2% | +11.1% |
| Oct 2 | BofA Securities | Downgrade | Buy → Underperform | — | $91.75 | $90.50 | -1.4% | -2.5% | -13.9% | -12.5% | -14.2% | -14.2% |
| Aug 9 | Deutsche Bank | Maintains | Hold → Hold | — | $140.00 | $138.50 | -1.1% | -1.4% | -4.8% | -0.4% | -8.4% | -12.1% |
| Aug 8 | Benchmark | Maintains | Buy → Buy | — | $141.00 | $142.50 | +1.1% | -0.7% | -2.1% | -5.5% | -1.1% | -9.0% |
| Aug 7 | RBC Capital | Maintains | Outperform → Outperform | — | $155.50 | $155.50 | +0.0% | -9.3% | -10.0% | -11.3% | -14.3% | -10.3% |
| Jul 9 | Evercore ISI | Maintains | In Line → In Line | — | $151.00 | $150.00 | -0.7% | -4.8% | -6.6% | +1.8% | +4.1% | +8.3% |
| May 24 | Truist | Maintains | Hold → Hold | — | $141.25 | $142.75 | +1.1% | +7.8% | +8.1% | +1.9% | +10.4% | +11.5% |
No insider trades available.
8-K · 5.02
!!! Very High
agilon health, inc. -- 8-K 5.02: Executive Change
Agilon Health (AGL) appointed O'Rourke as Chief Executive Officer and President effective May 7, 2026, signaling leadership transition that investors should monitor for strategic direction changes.
Apr 27
8-K · 5.03
! Medium
Unknown — 8-K 5.03: Amendment to Articles / Bylaws
AGL shareholders approved charter amendments at a special meeting, potentially altering governance structure or operational authority, which could affect future decision-making flexibility and shareholder rights.
Mar 30
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
AGL is executing a reverse stock split, which consolidates shares but doesn't increase intrinsic value—investors should watch for post-split price momentum and whether this signals financial distress or restructuring needs.
Mar 18
8-K · 7.01
! Medium
agilon health, inc. -- 8-K 7.01: Regulation FD Disclosure
Agilon Health disclosed its Q4 2025 and full-year financial results through an investor presentation, providing shareholders with updated performance metrics and operational guidance.
Feb 25
8-K · 1.01
! Medium
agilon health, inc. -- 8-K 1.01: Financing / Debt Agreement
Agilon Health amended its debt agreement on February 12, 2026, modifying existing financing terms, though specific details about the amendment's financial impact require reviewing the full agreement.
Feb 12
Data updated apr 24, 2026 4:34pm
· Source: massive.com